Tongli Pharmaceuticals (USA), Inc.: key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2012)
- $11.1M
- Net Income/Loss (FY2012)
- $1.5M
- Total Assets (FY2012)
- $22.1M
- Total Equity (FY2012)
- $20.5M
- Cash Flows from Operating Activities (FY2012)
- $6.0M
Source: Tongli Pharmaceuticals (USA), Inc. 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
